These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 6690763)

  • 1. Propranolol and spurious hyperbilirubinemia.
    Belsey R; Mueggler P; Swanson JR
    JAMA; 1984 Jan; 251(1):38. PubMed ID: 6690763
    [No Abstract]   [Full Text] [Related]  

  • 2. Spurious hyperbilirubinemia in uremic patients on propranolol therapy.
    Stone WJ; McKinney TD; Warnock LG
    Clin Chem; 1979 Oct; 25(10):1761-5. PubMed ID: 476926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Yellowish discoloration of dialyzer.
    Chiew YW; Peng SJ; Yang CS
    Hemodial Int; 2012 Jul; 16(3):444-6. PubMed ID: 22103860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood levels of long-acting propranolol in normal subjects and patients with renal failure.
    Kawasaki T; Ueno M; Uezono K; Abe I; Kawazoe N; Omae T; Nakamura S; Cooper RG; Stafford LE
    Fukuoka Igaku Zasshi; 1983 Nov; 74(11):737-43. PubMed ID: 6676140
    [No Abstract]   [Full Text] [Related]  

  • 5. [Pharmacokinetics of propranolol and clonidine in patients during chronic intermittent hemodialysis treatment].
    Seiler KU; Hunecke R; Meyer GJ
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1612-4. PubMed ID: 611890
    [No Abstract]   [Full Text] [Related]  

  • 6. Increase in serum potassium caused by beta-2 adrenergic blockade in terminal renal failure: absence of mediation by insulin or aldosterone.
    Arrizabalaga P; Montoliu J; Martinez Vea A; Andreu L; López Pedret J; Revert L
    Proc Eur Dial Transplant Assoc; 1983; 20():572-6. PubMed ID: 6318223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interference of a propranolol metabolite with serum bilirubin estimation in chronic renal failure.
    al-Damluji S; Meek JH
    Br Med J; 1980 Jun; 280(6229):1414. PubMed ID: 7427135
    [No Abstract]   [Full Text] [Related]  

  • 8. [Oxaloacetic transaminase, lactate dehydrogenase, alkaline phosphatase and bilirubin in patients on chronic hemodialysis].
    Degoulet P; Rahmi R; Piette Y
    Union Med Can; 1973 Aug; 103(8):1644-9. PubMed ID: 4792851
    [No Abstract]   [Full Text] [Related]  

  • 9. Bilirubinemia and renal failure.
    Fulop M
    N Engl J Med; 1967 May; 276(21):1208-9. PubMed ID: 6023244
    [No Abstract]   [Full Text] [Related]  

  • 10. [Pharmacokinetics of propranolol in patients with chronic renal insufficiency undergoing hemodialysis].
    Flouvat B; Decourt S; Potaux L
    Therapie; 1979; 34(1):63-72. PubMed ID: 483227
    [No Abstract]   [Full Text] [Related]  

  • 11. Beta-adrenergic-mediated extrarenal potassium disposal in patients with end-stage renal disease: effect of propranolol.
    Yang WC; Huang TP; Ho LT; Chung HM; Chan YL; Batlle DC
    Miner Electrolyte Metab; 1986; 12(3):186-93. PubMed ID: 2873504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Propranolol in the control of arterial hypertension in patients with chronic renal insufficiency].
    De Sancho JL; Muñíz R; Gómez-Ullate P; Orofino L; Villar F; Lampreabe I; García Damborenea R
    Rev Clin Esp; 1975 Apr; 137(2):145-50. PubMed ID: 1144843
    [No Abstract]   [Full Text] [Related]  

  • 13. [Lowering of serum bilirubin following experimental ligation of the bile duct. Affinity-chromatography binding of bilirubin to albumin conjugated with agarose].
    Lehr L
    Langenbecks Arch Chir; 1975; Suppl():19-24. PubMed ID: 1207228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Letter: Hypoglycaemia in propranolol-treated dialysis patients.
    Jensen HA; Bjaeldager P; Broch-Moller B
    Lancet; 1976 Aug; 2(7981):368-9. PubMed ID: 60600
    [No Abstract]   [Full Text] [Related]  

  • 15. Bilirubin removal by hemoperfusion through carbon and by in vivo immobilized enzymes.
    Freston JW; Work JW; Denti E
    Kidney Int Suppl; 1976 Dec; (7):S229-32. PubMed ID: 827651
    [No Abstract]   [Full Text] [Related]  

  • 16. [Comparative studies with propranolol, verapamil and atenolol in hypertensive dialysis patients].
    Hepp A; Maisch B; Raff U; Hayduk K
    Verh Dtsch Ges Kreislaufforsch; 1977; 43():239. PubMed ID: 613588
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of serum from renal failure and cirrhotic patients on the blood-brain barrier permeability to DL-propranolol in rats.
    Lin TH; Sugiyama Y; Sawada Y; Kawasaki S; Iga T; Hanano M
    Drug Metab Dispos; 1988; 16(2):290-5. PubMed ID: 2898349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effective bilirubin reduction by single-pass albumin dialysis in liver failure.
    Boonsrirat U; Tiranathanagul K; Srisawat N; Susantitaphong P; Komolmit P; Praditpornsilpa K; Tungsanga K; Eiam-Ong S
    Artif Organs; 2009 Aug; 33(8):648-53. PubMed ID: 19624591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of dialysis on plasma cortisol concentration in patients with renal failure].
    Szewczyk Z; Silber D; Skiba W; Checińska E; Szepietowski T; Kopeć W
    Pol Tyg Lek; 1975 Dec; 30(49):2037-40. PubMed ID: 1197088
    [No Abstract]   [Full Text] [Related]  

  • 20. [Compartive findings in the study of the kinetics of bilirubin in chronic hyperbilirubinemia. Use of overloads of crystalline bilirubin].
    Ghidini O; Vallaperta P; Tomasi A; Battocchia A
    Recenti Prog Med; 1973 Jul; 55(1):1-23. PubMed ID: 4800778
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.